2,009
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Effects of platelets activated by different agonists on fibrin formation and thrombin generation

, , , &
Article: 2139365 | Received 06 May 2022, Accepted 18 Oct 2022, Published online: 02 Nov 2022

References

  • Rosing J, van Rijn JL, Bevers EM, van Dieijen G, Comfurius P, Zwaal RF. The role of activated human platelets in prothrombin and factor X activation. Blood. 1985;65(2):1–8. doi:10.1182/blood.V65.2.319.319.
  • Kempton CL, Hoffman M, Roberts HR, Monroe DM. Platelet Heterogeneity Variation in coagulation complexes on platelet subpopulations. Arterioscler Thromb Vasc Biol. 2005;25(4):861–866. doi:10.1161/01.ATV.0000155987.26583.9b.
  • Panteleev MA, Ananyeva NM, Greco NJ, Ataullakhanov FI, Saenko EL. Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complex. J Thromb Haemost. 2005;3(11):2545–2553. doi:10.1111/j.1538-7836.2005.01616.x.
  • Heemskerk JWM, Mattheij NJA, Cosemans JMEM. Platelet-based coagulation: different populations, different functions. J Thromb Haemost. 2013;11(1):2–16. doi:10.1111/jth.12045.
  • Podoplelova NA, Sveshnikova AN, Kotova YN, Eckly A, Receveur N, Nechipurenko DY, Obydennyi SI, Kireev II, Gachet C, Ataullakhanov FI, et al. Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting. Blood. 2016;128(13):1745–1755. doi:10.1182/blood-2016-02-696898.
  • Reddy EC, Rand ML. Procoagulant phosphatidylserine-exposing platelets in vitro and in vivo. Front Cardiovasc Med. 2020;7:15. doi:10.3389/fcvm.2020.00015.
  • Altman R, Scazziota A, Rouvier J, Gonzalez C. Effect of sodium arachidonate on thrombin generation through platelet activation – inhibitory effect of aspirin. Thromb Haemost. 2000;84(12):1109–1112. doi:10.1055/s-0037-1614178.
  • Altman R, Scazziota A, de Lourdes Herrera M, Gonzalez C. Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation. J Thromb Haemost. 2006;4(9):2022–2027. doi:10.1111/j.1538-7836.2006.02088.x.
  • Altman R, Scazziota AS, de Lourdes Herrera M, Gonzalez C. Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis. Thromb J. 2006;4(1):5. doi:10.1186/1477-9560-4-5.
  • Didelot M, Docq C, Wahl D, Lacolley P, Regnault V, Lagrange J. Platelet aggregation impacts thrombin generation assessed by calibrated automated thrombography. Platelets. 2018;29(2):156–161. doi:10.1080/09537104.2017.1356452.
  • Panova-Noeva M, van der Meijden PEG, ten Cate H. Clinical applications, pitfalls, and uncertainties of thrombin generation in the presence of platelets. J Clin Med. 2020;9(1):92. doi:10.3390/jcm9010092.
  • Wan J, Konings J, de Laat B, Hackeng TM, Roest M. Added value of blood cells in thrombin generation testing. Thromb Haemost. 2021;121(12):1574–1587. 10.1055/a-1450-8300.
  • Reikvam H, Steien E, Hauge B, Knut Liseth K, Hagen KG, Størkson R, Hervig T. Thrombelastography. Transfus Apher Sci. 2009;40(2):119–123. doi:10.1016/j.transci.2009.01.019.
  • Racine-Brzostek SE, Asmis LM. Assessment of platelet function utilizing viscoelastic testing. Transfusion. 2020;60(S6):S10–20. 10.1111/trf.16081.
  • Swieringa F, Baaten CCFMJ, Verdoold R, Mastenbroek TG, Rijnveld N, van der Laan KO, Breel EJ, Collins PW, Lancé MD, Henskens YMC, et al. Platelet control of fibrin distribution and microelasticity in thrombus formation under flow. Arterioscler Thromb Vasc Biol. 2016;36(4):692–699. doi:10.1161/ATVBAHA.115.306537.
  • Brouns SLN, van Geffen JP, Campello E, Swieringa F, Spiezia L, van Oerle R, Provenzale I, Verdoold R, Farndale RW, Clemetson KJ, et al. Platelet-primed interactions of coagulation and anticoagulation pathways in flow-dependent thrombus formation. Sci Rep. 2020;10(1):11910. doi:10.1038/s41598-020-68438-9.
  • Navarro S, Stegner D, Nieswandt B, Heemskerk JWM, Kuijpers MJE. Temporal roles of platelet and coagulation pathways in collagen- and tissue factor-induced thrombus formation. Int J Mol Sci. 2021;23(1):358. doi:10.3390/ijms23010358.
  • Khaspekova SG, Antonova OA, Shustova ON, Yakushkin VV, Golubeva NV, Titaeva EV, Dobrovolsky AB, Mazurov AV. Activity of tissue factor in microparticles produced in vitro by endothelial cells, monocytes, granulocytes, and platelets. Biochem Moscow. 2016;81(2):114–121. doi:10.1134/S000629791602005X.
  • Aleman MM, Gardiner C, Harrison P, Wolberg AS. Differential contribution of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J Thromb Haemost. 2011;9(11):2251–2261. doi:10.1111/j.1538-7836.2011.04488.x.
  • Van der Meijden PE, van Schilfgaarde M, van Oerle R, Renné T, ten Cate H, Spronk HM. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. J Thromb Haemost. 2012;10(7):1355–1362. doi:10.1111/j.1538-7836.2012.04758.x.
  • Tripisciano C, Weiss R, Eichhorn T, Spittler A, Heuser T, Fischer MB, Weber V. Different potential of extracellular vesicles to support thrombin generation: contributions of phosphatidylserine, tissue factor, and cellular origin. Sci Rep. 2017;7(1):6522. doi:10.1038/s41598-017-03262-2.
  • Shustova ON, Antonova OA, Golubeva NV, Khaspekova SG, Yakushkin VV, Aksuk SA, Alchinova IB, Karganov MY, Mazurov AV. Differential procoagulant activity of microparticles derived from monocytes, granulocytes, platelets and endothelial cells: impact of active tissue factor. Blood Coagul Fibrinolys. 2017;28(5):373–382. doi:10.1097/MBC.0000000000000609.
  • Lipets EN, Antonova OA, Shustova ON, Losenkova KV, Mazurov AV, Ataullakhanov FI. Use of Thrombodynamics for revealing the participation of platelet, erythrocyte, endothelial, and monocyte microparticles in coagulation activation and propagation. PLoS ONE. 2020;15(5):e0227932. doi:10.1371/journal.pone.0227932.
  • Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost. 2007;97(03):425–434. doi:10.1160/TH06-06-0313.
  • Thiagarajan P, Tait JF. Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem. 1990;265(29):17420–17423. doi:10.1016/S0021-9258(18)38177-8.
  • Ramstrom S, Ranby M, Lindahl TL. Platelet phosphatidylserine exposure and procoagulant activity in clotting whole blood – different effects of collagen, TRAP and calcium ionophore A23187. Thromb Haemost. 2003;89(01):132–141. doi:10.1055/s-0037-1613552.
  • Rukoyatkina N, Shpakova V, Panteleev M, Kharazova A, Gambaryan S, Geiger J. Multifaceted effects of arachidonic acid and interaction with cyclic nucleotides in human platelets. Thromb Res. 2018;171:22–30. doi:10.1016/j.thromres.2018.09.047.